{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:14:24Z","timestamp":1771938864491,"version":"3.50.1"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: This study investigated the systemic metabolic effects of two probiotic strains, Lacticaseibacillus paracasei MG5012 and Bifidobacterium animalis subsp. lactis MG741, on metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity-related muscle dysfunction in high-fat-diet (HFD)-induced obese mice. Methods: Obesity was induced in C57BL\/6 mice via high-fat diet (HFD) feeding for 6 weeks. Subsequently, the mice were orally administered MG5012 or MG741 for 8 weeks. We assessed systemic metabolic parameters, including body weight, adiposity, and serum biomarkers. Additionally, histological and molecular analyses were performed to evaluate hepatic steatosis, intestinal barrier integrity, and muscle oxidative status. Results: Both strains significantly attenuated body weight gain and adiposity, reduced serum liver injury markers (\u03b3-GTP, ALT, AST), and improved systemic metabolic parameters by restoring serum GLP-1 levels and reducing hyperinsulinemia. Crucially, MG5012 and MG741 strengthened intestinal barrier integrity by upregulating the tight junction proteins Occludin and Claudin-1. In the liver, histological analyses revealed reductions in hepatic steatosis and triglyceride content, accompanied by the downregulation of lipogenic genes (SREBP-1c, FAS). Furthermore, the probiotics preserved skeletal muscle integrity; while muscle weight remained unchanged, the strains increased muscle fiber cross-sectional area (CSA) and reduced serum markers of muscle damage (CPK, LDH). This protective effect was associated with significantly enhanced expression of antioxidant enzymes (SOD, CAT, GPx) in muscle tissue. Conclusions: These findings suggest that MG5012 and MG741 confer systemic metabolic benefits through the modulation of the gut\u2013liver\u2013muscle axis and may serve as promising functional food ingredients for the management of MASLD and obesity-associated muscle atrophy.<\/jats:p>","DOI":"10.3390\/nu18050715","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:19:23Z","timestamp":1771935563000},"page":"715","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lacticaseibacillus paracasei MG5012 and Bifidobacterium animalis subsp. lactis MG741 Alleviate Metabolic Dysfunction-Associated Steatotic Liver Disease and Preserve Skeletal Muscle Integrity in High-Fat-Diet-Fed Mice"],"prefix":"10.3390","volume":"18","author":[{"given":"Miran","family":"Jang","sequence":"first","affiliation":[{"name":"Department of Food Technology and Nutrition, Inje University, Gimhae 50834, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Yeon","family":"Lee","sequence":"additional","affiliation":[{"name":"MEDIOGEN, Co., Ltd., Biovalley 1-ro, Jecheon 27159, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-Yong","family":"Park","sequence":"additional","affiliation":[{"name":"MEDIOGEN, Co., Ltd., Biovalley 1-ro, Jecheon 27159, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8362-3523","authenticated-orcid":false,"given":"Soo-Im","family":"Choi","sequence":"additional","affiliation":[{"name":"MEDIOGEN, Co., Ltd., Biovalley 1-ro, Jecheon 27159, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung-Kook","family":"Kim","sequence":"additional","affiliation":[{"name":"MEDIOGEN, Co., Ltd., Biovalley 1-ro, Jecheon 27159, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/eurjpc\/zwae025","article-title":"Obesity and cardiovascular health","volume":"31","author":"Welsh","year":"2024","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Li, Y., Guo, W., Li, H., Wang, Y., Liu, X., and Kong, W. (2025). The change of skeletal muscle caused by inflammation in obesity as the key path to fibrosis: Thoughts on mechanisms and intervention strategies. Biomolecules, 15.","DOI":"10.3390\/biom15010020"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11154-025-09954-9","article-title":"Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved","volume":"26","author":"Rueda","year":"2025","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"109199","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanisms","volume":"330","author":"Lian","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Berardo, C., Di Pasqua, L.G., Cagna, M., Richelmi, P., Vairetti, M., and Ferrigno, A. (2020). Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249646"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100149","DOI":"10.1016\/j.metop.2021.100149","article-title":"Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)","volume":"12","author":"Zarghamravanbakhsh","year":"2021","journal-title":"Metab. Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4239\/wjd.v6.i3.456","article-title":"Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus","volume":"6","author":"Tangvarasittichai","year":"2015","journal-title":"World J. Diabetes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41392-022-01149-x","article-title":"Signaling pathways in obesity: Mechanisms and therapeutic interventions","volume":"7","author":"Wen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_11","first-page":"351","article-title":"Sarcopenic obesity and weight loss-induced muscle mass loss","volume":"28","author":"Caturano","year":"2025","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15518","DOI":"10.3748\/wjg.v20.i42.15518","article-title":"Gut\u2013Liver Axis and Probiotics: Their Role in Non-Alcoholic Fatty Liver Disease","volume":"20","author":"Paolella","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4183880","DOI":"10.1155\/2024\/4183880","article-title":"The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies","volume":"2024","author":"Yaghmaei","year":"2024","journal-title":"Int. J. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107694","DOI":"10.1016\/j.phrs.2025.107694","article-title":"Probiotics for the Treatment of Hyperlipidemia: Focus on Gut\u2013Liver Axis and Lipid Metabolism","volume":"214","author":"You","year":"2025","journal-title":"Pharmacol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wei, S., Nguyen, T.T., Zhang, Y., Ryu, D., and Gariani, K. (2023). Sarcopenic obesity: Epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1185221"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Won, G., Choi, S.I., Kang, C.H., and Kim, G.H. (2021). Lactiplantibacillus plantarum MG4296 and Lacticaseibacillus paracasei MG5012 Ameliorate Insulin Resistance in Palmitic Acid-Induced HepG2 Cells and High-Fat Diet-Induced Mice. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061139"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Do, M.H., Oh, M.J., Lee, H.B., Kang, C.H., Yoo, G., and Park, H.Y. (2022). Bifidobacterium animalis ssp. lactis MG741 Reduces Body Weight and Ameliorates Nonalcoholic Fatty Liver Disease via Improving Gut Permeability and Inflammatory Cytokines. Nutrients, 14.","DOI":"10.3390\/nu14091965"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ma, J., Zhou, Q., and Li, H. (2017). Gut microbiota and nonalcoholic fatty liver disease: Insights on mechanisms and therapy. Nutrients, 9.","DOI":"10.20944\/preprints201709.0040.v1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jnutbio.2018.07.009","article-title":"Liraglutide modulates gut microbiota and reduces NAFLD in obese mice","volume":"62","author":"Moreira","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1080\/02664763.2010.545119","article-title":"Features and Performance of Some Outlier Detection Methods","volume":"38","author":"Giulio","year":"2011","journal-title":"J. Appl. Stat."},{"key":"ref_21","first-page":"119300","article-title":"GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R\/AMPK pathway","volume":"1869","author":"Wu","year":"2022","journal-title":"BBA Mol. Cell Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2010.09.032","article-title":"Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase","volume":"54","author":"Zvibel","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/CIRCRESAHA.116.308750","article-title":"Chronic Kidney Disease Induces Inflammatory CD40+ Monocyte Differentiation via Homocysteine Elevation and DNA Hypomethylation","volume":"119","author":"Yang","year":"2016","journal-title":"Circ. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD Development and Therapeutic Strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Nevola, R., Epifani, R., Imbriani, S., Tortorella, G., Aprea, C., Galiero, R., Rinaldi, L., Marfella, R., and Sasso, F.C. (2023). GLP-1 receptor agonists in non-alcoholic fatty liver disease: Current evidence and future perspectives. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021703"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.celrep.2017.10.008","article-title":"Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion","volume":"21","author":"Lebrun","year":"2017","journal-title":"Cell Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1074\/jbc.M111.310342","article-title":"Regulation of adipocyte formation by GLP-1\/GLP-1R signaling","volume":"287","author":"Challa","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(23)01185-6","article-title":"Oral semaglutide 50 mg taken once daily in adults with overweight or obesity (OASIS 1): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"402","author":"Knop","year":"2023","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2200496","DOI":"10.1002\/mnfr.202200496","article-title":"The PKA-SREBP1c Pathway Plays a Key Role in the Protective Effects of Lactobacillus johnsonii JNU3402 Against Diet-Induced Fatty Liver in Mice","volume":"67","author":"Hong","year":"2023","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.12938\/bmfh.2024-074","article-title":"Administration of a probiotic supplement attenuates nonalcoholic fatty liver disease by reducing hepatic lipid accumulation, oxidative stress, and inflammation","volume":"44","author":"Chonpathompikunlert","year":"2024","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1210\/clinem\/dgac613","article-title":"Effects of GLP-1 Infusion Upon Whole-Body Glucose Uptake and Skeletal Muscle Perfusion During Fed State in Older Men","volume":"108","author":"Abdulla","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41538-025-00698-z","article-title":"Composite dietary fiber alleviates obesity-induced skeletal muscle atrophy by regulating gut microbiota-derived short-chain fatty acids in mice","volume":"10","author":"Xie","year":"2026","journal-title":"npj Sci. Food"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic Endotoxemia Initiates Obesity and Insulin Resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet\u2013Induced Obesity and Diabetes in Mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4014\/jmb.2310.10026","article-title":"Hepatoprotective Effect of Lactiplantibacillus plantarum DSR330 in Mice with High Fat Diet-Induced Nonalcoholic Fatty Liver Disease","volume":"34","author":"Lee","year":"2024","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zhu, J., Peng, F., Yang, H., Luo, J., Zhang, L., Chen, X., Liao, H., Lei, H., Liu, S., and Yang, T. (2025). Probiotics and Muscle Health: The Impact of Lactobacillus on Sarcopenia through the Gut-Muscle Axis. Front. Microbiol., 16.","DOI":"10.3389\/fmicb.2025.1559119"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Maldonado, J., Gil-Campos, M., Maldonado-Lob\u00f3n, J.A., Benavides, M.R., Flores-Rojas, K., Jaldo, R., del Barco, I.J., Bol\u00edvar, V., Valero, A.D., and Prados, E. (2019). Evaluation of the Safety, Tolerance and Efficacy of 1-Year Consumption of Infant Formula Supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: A Randomized Controlled Trial. BMC Pediatr., 19.","DOI":"10.1186\/s12887-019-1753-7"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Arrieta, M.C., Stiemsma, L.T., Amenyogbe, N., Brown, E.M., and Finlay, B. (2014). The intestinal microbiome in early life: Health and disease. Front. Immunol., 5.","DOI":"10.3389\/fimmu.2014.00427"},{"key":"ref_41","first-page":"95","article-title":"The human milk microbiome and factors influencing its composition and activity","volume":"21","author":"Salminen","year":"2016","journal-title":"Semin. Fetal Neonatal Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/msb4100190","article-title":"Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model","volume":"4","author":"Martin","year":"2008","journal-title":"Mol. Syst. Biol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/5\/715\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T12:36:09Z","timestamp":1771936569000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/5\/715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["nu18050715"],"URL":"https:\/\/doi.org\/10.3390\/nu18050715","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}